Singular Genomics Systems, Inc.
OMICDelisted Feb 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001850906
Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding Singular Genomics Systems, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 20 | 0 | −20 |
| Shares | 1.11M | 0 | −1.11M (−100.0%) |
| Value | $21.5M | $0 | −$21.5M (−100.0%) |
New holders (0)
Institutions that held Singular Genomics Systems, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
None.
Sold out (20)
Institutions that held Singular Genomics Systems, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Tang Capital Management LLC | 372,000 | $7.23M |
| Deerfield Management Company, L.P. (Series C) | 166,162 | $3.23M |
| UBS Group AG | 156,254 | $3.04M |
| ARCH Venture Management, LLC | 126,630 | $2.46M |
| QVIDTVM Management LLC | 83,671 | $1.63M |
| FMR LLC | 70,653 | $1.37M |
| Vanguard Group Inc | 62,418 | $1.21M |
| Geode Capital Management, LLC | 17,990 | $349.8K |
| HighTower Advisors, LLC | 17,607 | $342.1K |
| BlackRock, Inc. | 15,165 | $294.7K |
| Tikvah Management LLC | 10,561 | $205.2K |
| PenderFund Capital Management Ltd. | 2,105 | $59.3K |
| JPMorgan Chase & Co | 1,944 | $38.1K |
| Morgan Stanley | 1,896 | $36.8K |
| Tower Research Capital LLC (TRC) | 1,189 | $23.1K |
| Barclays PLC | 409 | $7.95K |
| Bank of America Corp | 369 | $7.17K |
| Royal Bank of Canada | 67 | $1.00K |
| BNP Paribas Arbitrage, SA | 34 | $661 |
| Harbour Investments, Inc. | 5 | $97 |